These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 18538742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Vitreomacular Adhesion and the Risk of Neovascular Age-Related Macular Degeneration.
    Maggio E, Polito A, Guerriero M, Prigione G, Parolini B, Pertile G.
    Ophthalmology; 2017 May; 124(5):657-666. PubMed ID: 28214102
    [Abstract] [Full Text] [Related]

  • 3. Posterior vitreomacular adhesion and risk of exudative age-related macular degeneration: paired eye study.
    Lee SJ, Lee CS, Koh HJ.
    Am J Ophthalmol; 2009 Apr; 147(4):621-626.e1. PubMed ID: 19159862
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for exudative age-related macular degeneration.
    Lee SJ, Koh HJ.
    Ophthalmology; 2011 Jan; 118(1):101-10. PubMed ID: 20678805
    [Abstract] [Full Text] [Related]

  • 7. [Vitreomacular interface and posterior vitreomacular adhesion in exudative age-related macular degeneration (AMD): an OCT-based comparative study].
    Maier M, Pfrommer S, Burzer S, Feucht N, Winkler von Mohrenfels C, Lohmann CP.
    Klin Monbl Augenheilkd; 2012 Oct; 229(10):1030-5. PubMed ID: 23096146
    [Abstract] [Full Text] [Related]

  • 8. Prognostic factors associated with the course of vitreomacular traction in eyes with age-related macular degeneration.
    Garip R, Çınar AK, Çınar AC, Sakallıoğlu AK, Güçlü H, Gürlü V.
    Photodiagnosis Photodyn Ther; 2022 Dec; 40():103025. PubMed ID: 35870775
    [Abstract] [Full Text] [Related]

  • 9. VITREOMACULAR TRACTION AFFECTS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT OUTCOMES FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION.
    Krishnan R, Arora R, De Salvo G, Stinghe A, Severn PS, Pal B, Goverdhan S.
    Retina; 2015 Sep; 35(9):1750-6. PubMed ID: 26237240
    [Abstract] [Full Text] [Related]

  • 10. The Role of Posterior Vitreous Detachment and Vitreomacular Adhesion in Patients With Age-Related Macular Degeneration.
    Ilim O, Akkin C, Oztas Z, Nalcaci S, Afrashi F, Degirmenci C, Mentes J.
    Ophthalmic Surg Lasers Imaging Retina; 2017 Mar 01; 48(3):223-229. PubMed ID: 28297034
    [Abstract] [Full Text] [Related]

  • 11. Long-term evaluation of vitreomacular traction disorder in spectral-domain optical coherence tomography.
    Odrobina D, Michalewska Z, Michalewski J, Dzięgielewski K, Nawrocki J.
    Retina; 2011 Feb 01; 31(2):324-31. PubMed ID: 21416651
    [Abstract] [Full Text] [Related]

  • 12. Three-dimensional evaluation of vitreomacular traction and epiretinal membrane using spectral-domain optical coherence tomography.
    Koizumi H, Spaide RF, Fisher YL, Freund KB, Klancnik JM, Yannuzzi LA.
    Am J Ophthalmol; 2008 Mar 01; 145(3):509-517. PubMed ID: 18191099
    [Abstract] [Full Text] [Related]

  • 13. ASSOCIATION BETWEEN THE VITREOMACULAR INTERFACE AND OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS IN WET AGE-RELATED MACULAR DEGENERATION.
    Ashraf M, Souka A, Adelman RA.
    Retina; 2017 Sep 01; 37(9):1738-1745. PubMed ID: 28005632
    [Abstract] [Full Text] [Related]

  • 14. Spectral domain optical coherence tomography for higher precision in the evaluation of vitreoretinal adhesions in exudative age-related macular degeneration.
    Krebs I, Glittenberg C, Zeiler F, Binder S.
    Br J Ophthalmol; 2011 Oct 01; 95(10):1415-8. PubMed ID: 21270433
    [Abstract] [Full Text] [Related]

  • 15. A novel spectral-domain optical coherence tomography model to estimate changes in vitreomacular traction syndrome.
    Codenotti M, Iuliano L, Fogliato G, Querques G, Bandello F.
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov 01; 252(11):1729-35. PubMed ID: 24764038
    [Abstract] [Full Text] [Related]

  • 16. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Ciulla TA, Ying GS, Maguire MG, Martin DF, Jaffe GJ, Grunwald JE, Daniel E, Toth CA, Comparison of Age-Related Macular Degeneration Treatments Trials Research Group.
    Ophthalmology; 2015 Jun 01; 122(6):1203-11. PubMed ID: 25824327
    [Abstract] [Full Text] [Related]

  • 17. Correlation of Vitreomacular Traction with Foveal Thickness, Subfoveal Choroidal Thickness, and Vitreomacular/Foveal Angle.
    Kozak I, Barteselli G, Sepah YJ, Sadiq MA, High R, Do DV, Nguyen QD.
    Curr Eye Res; 2017 Feb 01; 42(2):297-301. PubMed ID: 27362467
    [Abstract] [Full Text] [Related]

  • 18. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE, Kanadani TM, Pereira FB, Nehemy MB.
    Ophthalmology; 2015 Aug 01; 122(8):1569-72. PubMed ID: 26038338
    [Abstract] [Full Text] [Related]

  • 19. Natural course of vitreomacular traction syndrome observed by spectral-domain optical coherence tomography.
    Zhang Z, Dong F, Zhao C, Dai R, Yu W, Zheng L, He F, Yang Z.
    Can J Ophthalmol; 2015 Apr 01; 50(2):172-9. PubMed ID: 25863860
    [Abstract] [Full Text] [Related]

  • 20. Influence of vitreomacular interface on anti-vascular endothelial growth factor treatment outcomes in neovascular age-related macular degeneration: A MOOSE-compliant meta-analysis.
    Gao M, Liu L, Liang X, Yu Y, Liu X, Liu W.
    Medicine (Baltimore); 2017 Dec 01; 96(50):e9345. PubMed ID: 29390407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.